Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

PURPOSE: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) from the perspective of the Canadian public healthcare system. METHODS: We developed a Markov st...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hannouf, Malek B., Sehgal, Chander, Cao, Jeffrey Q., Mocanu, Joseph D., Winquist, Eric, Zaric, Gregory S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2012
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379991/
https://ncbi.nlm.nih.gov/pubmed/22745668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0038557
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia